These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30805315)

  • 41. Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosum.
    Brun J; Mahoney DJ; Le Boeuf F; Lefebvre C; Sanaei CA; Falls T; Mccart JA; Stojdl DF
    Int J Cancer; 2013 Feb; 132(3):726-31. PubMed ID: 22733395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594.
    Breitbach CJ; Thorne SH; Bell JC; Kirn DH
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1768-72. PubMed ID: 21740365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy.
    Xu H; Buhtoiarov IN; Guo H; Cheung NV
    Oncoimmunology; 2021 Mar; 10(1):1893500. PubMed ID: 33763293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model.
    Niu Z; Bai F; Sun T; Tian H; Yu D; Yin J; Li S; Li T; Cao H; Yu Q; Wu Y; Ren G; Li D
    Technol Cancer Res Treat; 2015 Oct; 14(5):607-15. PubMed ID: 24645750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of Tumors.
    Wang J; Arulanandam R; Wassenaar R; Falls T; Petryk J; Paget J; Garson K; Cemeus C; Vanderhyden BC; Wells RG; Bell JC; Le Boeuf F
    J Nucl Med; 2017 Feb; 58(2):221-227. PubMed ID: 27635026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells
    Kaid C; Goulart E; Caires-Júnior LC; Araujo BHS; Soares-Schanoski A; Bueno HMS; Telles-Silva KA; Astray RM; Assoni AF; Júnior AFR; Ventini DC; Puglia ALP; Gomes RP; Zatz M; Okamoto OK
    Cancer Res; 2018 Jun; 78(12):3363-3374. PubMed ID: 29700002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.
    Lun X; Yang W; Alain T; Shi ZQ; Muzik H; Barrett JW; McFadden G; Bell J; Hamilton MG; Senger DL; Forsyth PA
    Cancer Res; 2005 Nov; 65(21):9982-9990. PubMed ID: 16267023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic Characterization of the Biodistribution of the Oncolytic Virus M1.
    Cai J; Zhu W; Lin Y; Zhang S; Chen X; Gong S; He S; Hu J; Yan G; Liang J
    Hum Gene Ther; 2020 Nov; 31(21-22):1203-1213. PubMed ID: 32829653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.
    Stanford MM; Barrett JW; Nazarian SH; Werden S; McFadden G
    J Virol; 2007 Feb; 81(3):1251-60. PubMed ID: 17108021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner.
    Polansky JK; Bahri R; Divivier M; Duitman EH; Vock C; Goyeneche-Patino DA; Orinska Z; Bulfone-Paus S
    Sci Rep; 2016 Jan; 6():19699. PubMed ID: 26822794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.
    Ricordel M; Foloppe J; Antoine D; Findeli A; Kempf J; Cordier P; Gerbaud A; Grellier B; Lusky M; Quemeneur E; Erbs P
    Cancers (Basel); 2018 Jul; 10(7):. PubMed ID: 29996551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of glioma.
    Lun X; Chan J; Zhou H; Sun B; Kelly JJ; Stechishin OO; Bell JC; Parato K; Hu K; Vaillant D; Wang J; Liu TC; Breitbach C; Kirn D; Senger DL; Forsyth PA
    Mol Ther; 2010 Nov; 18(11):1927-36. PubMed ID: 20808290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.
    Guo ZS; Naik A; O'Malley ME; Popovic P; Demarco R; Hu Y; Yin X; Yang S; Zeh HJ; Moss B; Lotze MT; Bartlett DL
    Cancer Res; 2005 Nov; 65(21):9991-8. PubMed ID: 16267024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
    Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
    J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.
    Kim M; Williamson CT; Prudhomme J; Bebb DG; Riabowol K; Lee PW; Lees-Miller SP; Mori Y; Rahman MM; McFadden G; Johnston RN
    Oncogene; 2010 Jul; 29(27):3990-6. PubMed ID: 20473328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
    Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
    Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reovirus Neurotropism and Virulence Are Dictated by Sequences in the Head Domain of the Viral Attachment Protein.
    Sutherland DM; Aravamudhan P; Dietrich MH; Stehle T; Dermody TS
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas.
    Petrov I; Gentschev I; Vyalkova A; Elashry MI; Klymiuk MC; Arnhold S; Szalay AA
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32664672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deletion of
    Potts KG; Irwin CR; Favis NA; Pink DB; Vincent KM; Lewis JD; Moore RB; Hitt MM; Evans DH
    EMBO Mol Med; 2017 May; 9(5):638-654. PubMed ID: 28289079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.